Singapore · Biotechnology

Cerecin

Cerecin is a healthcare company that develops a novel evidence-based therapeutics and products that aim to help people.

PrivateFor profit

BiotechnologyAnson House, Singapore, Singapore

Against its peers

Set against 55 Biotechnology companies in Singapore. The ring marks the typical peer.

LinkedIn followers6k#5 of 36; the typical peer has 478
Staff11-50The typical size for its peers
Founded200110 years before the typical peer (2011)
Website traffic#13.1MQuieter than the typical peer's site (#8.6M)

Across all 5.9M companies: larger than 33% of those with a size listed; older than 40% of those with a founding year; website ranked #13,122,906 in the world, about 78 visits a month. 37 people list it on LinkedIn, and 6,008 follow it.

About Cerecin

Cerecin is a global healthcare company with more than 20 years of innovation and leadership in brain health. At Cerecin we think differently. We develop novel evidence-based solutions that help people; pharmaceuticals, medical foods, diagnostics, medical devices and e-health products. These solutions target conditions ranging from memory impairment to some of the most devastating neurological diseases.

What it does

BiotechnologyHealth CareLife ScienceTherapeuticsBiotechnologyBrain healthAlzheimer'sDrug developmentClinical researchKetone therapy

Known for

biotechnologybrain healthalzheimersdrug developmentclinical researchketone therapybiotechnology researchb2bketone precursorsfdg pet analogtricaprilinlipid nanoemulsionketone systemneuroprotectioninvestigational drugsketogenic drugs

Its website runs on

AWS CloudAmazon Route 53Microsoft Email ProvidersMicrosoft Exchange OnlineOutlookMicrosoft ExchangeMicrosoft 365Microsoft 365 Apps & ServicesAmazon AWSFont AwesomeAdobe FontsGoogle Tag ManagerPriority HintsApache HTTP ServerWordPress.orgCloudflare Rocket LoaderjQueryjQuery Migrate

Funding, as listed

What the source datasets report. We have not watched these rounds ourselves.

$77M

raised in total across 6 rounds

Last raised Sept 2022, 4 years ago

Rounds
6
Latest round
Series b
Latest amount
$3.7M
Investors
116 leading

Key facts

Who started it and how it trades.

Founded by
Mark Heiman, Samuel Henderson, Steve Orndorff
Annual revenue
$57M
NAICS code
541714, 325412

Every detail we hold

Everything the source datasets list about Cerecin, field by field. Contact details are held but never shown.

The company8 fields

Name
Cerecin
Type
For profit
Status
Private
Founded
2001
Founders
Mark Heiman, Samuel Henderson, Steve Orndorff
Industry
Biotechnology
Categories
Biotechnology, Health Care, Life Science, Therapeutics
Specialities
Biotechnology, Brain health, Alzheimer's, Drug development, Clinical research, Ketone therapy

Where4 fields

City
Anson House
Region
Singapore
Country
Singapore
Markets
Greater Denver Area, Western US

Size and reach6 fields

Staff band
11-50
People on LinkedIn
37
LinkedIn followers
6,008
Web traffic rank
#13,122,906
Monthly web visits
78
Annual revenue
$57M
Show 14 more fieldsShow fewer fields

Funding, as listed8 fields

Total
$77,344,167 USD
Rounds
6
Latest round
Series b
Latest round date
Sept 2022
Latest amount
3,740,000 USD
Investors
11
Lead investors
6
Listing status
private

Classification4 fields

NAICS
541714, 325412
SIC
2834, 8731
Keywords
16 listed, shown above
Technologies
18 detected, shown above

About this record2 fields

Sources
Crunchbase, LinkedIn, Apollo
Last imported
Sept 2026

Growth, as the source summarises it

Cerecin may be growing as it has strengthened its position in the neurometabolism market with a new addition to its pipeline. This expansion of its product pipeline indicates an active development phase and potential for increased market share in its sector. The company's focus on neurometabolism, a niche yet significant area within the healthcare industry, suggests a strategic approach to growth by targeting specialized therapeutic areas.

Companies like Cerecin

Biotechnology in Singapore.

Build a lead list

55 Biotechnology companies in Singapore, filtered by size, age and reach, ready to export with emails on Pro.

Open the list